Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging

被引:27
作者
Matusiak, Lukasz [1 ]
Bieniek, Andrzej [1 ]
Szepietowski, Jacek C. [1 ,2 ]
机构
[1] Med Univ, Dept Dermatol Venerol & Allergol, Wroclaw, Poland
[2] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland
关键词
Hidradenitis suppurativa; acne inversa; sIL-2R; WBC; leukocytosis; CRP; ESR; ATOPIC-DERMATITIS; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; ALOPECIA-AREATA; RECEPTOR; PSORIASIS; PARAMETERS; CHILDHOOD; LYMPHOMA; SIL-2R;
D O I
10.1080/13547500903075218
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hidradenitis suppurativa (HS) is a recurrent, debilitating suppurative skin disease. The major challenge is the choice of optimal treatment. Assessment of treatment effectiveness is currently associated with clinical observations of disease activity based on Hurley's or Sartorius' grading system. Detailed examination of patients with HS and evaluation of disease severity is frequently time-consuming and undoubtedly subjective. With regard to these factors, there is a need for laboratory findings that will help resolve the problem. The aim of this study was to determine the usefulness of soluble interleukin-2 receptor (sIL-2R) serum concentration as a marker of HS clinical staging and comparative analysis with the commonly conducted laboratory measurements, including white blood cell count, C-reactive protein and erythrocyte sedimentation rate. The statistical analysis of all these laboratory parameters conducted within a group of 54 individuals with HS revealed that sIL-2R serum level seems to be the most sensitive measurement for evaluation of disease stage. Moreover, the existence of strong dependences between sIL-2R serum concentration and Hurley's HS grading system were demonstrated. In conclusion, we believe that sIL-2R serum level could be used as a valuable marker for disease staging in patients with HS.
引用
收藏
页码:432 / 437
页数:6
相关论文
共 43 条
  • [1] Hidradenitis suppurativa: A comprehensive review
    Alikhan, Ali
    Lynch, Peter J.
    Eisen, Daniel B.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (04) : 539 - 561
  • [2] BETTINGER JR, 1991, PANCREAS S1, V6, P2
  • [3] CANOUIPOITRINE F, 2009, J AM ACAD DERMATOL, V28
  • [4] Chodorowska Grazyna, 2003, Ann Univ Mariae Curie Sklodowska Med, V58, P7
  • [5] SOLUBLE INTERLEUKIN-2 RECEPTOR IN ATOPIC ECZEMA
    COLVER, GB
    SYMONS, JA
    DUFF, GW
    [J]. BRITISH MEDICAL JOURNAL, 1989, 298 (6685) : 1426 - 1428
  • [6] deRie MA, 1996, ACTA DERM-VENEREOL, V76, P357
  • [7] EFFECT OF PROPYLTHIOURACIL AND METHIMAZOLE ON SERUM LEVELS OF INTERLEUKIN-2 RECEPTORS IN PATIENTS WITH PSORIASIS
    ELIAS, AN
    GOODMAN, MM
    ROHAN, MK
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 1993, 32 (07) : 537 - 540
  • [8] Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis
    Elkayam, O
    Yaron, I
    Shirazi, I
    Yaron, M
    Caspi, D
    [J]. RHEUMATOLOGY INTERNATIONAL, 2000, 19 (03) : 101 - 105
  • [9] Monitoring of serologic immune parameters in inflammatory skin diseases
    Gebhardt, M
    Wenzel, HC
    Hipler, UC
    Herrmann, D
    Wollina, U
    [J]. ALLERGY, 1997, 52 (11) : 1087 - 1094
  • [10] Altered innate and adaptive immune responses in patients with hidradenitis suppurativa
    Giamarellos-Bourboulis, E. J.
    Antonopoulou, A.
    Petropoulou, C.
    Mouktaroudi, M.
    Spyridaki, E.
    Baziaka, F.
    Pelekanou, A.
    Giamarellou, H.
    Stavrianeas, N. G.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (01) : 51 - 56